Is It Worth It? Consequences of Definitive Head and Neck Reirradiation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Is It Worth It? Consequences of Definitive Head and Neck Reirradiation

Published:2020-07 Issue:3 Volume:30 Page:212-217
ISSN:1053-4296
Container-title:Seminars in Radiation Oncology
language:en
Short-container-title:Seminars in Radiation Oncology

Author:

Foster Corey C.,Fan Ming,Lee Nancy Y.,Yom Sue S.,Heaton Chase M.,Deraniyagala Rohan,Amdur Robert,Weichselbaum Ralph R.,Haraf Daniel J.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Reference24 articles.

1. Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: The TREMPLIN randomized phase II study;Lefebvre;J Clin Oncol,2003

2. Long-term results of RTOG 91-11: A comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer;Forastiere;J Clin Oncol,2013

3. Target Volume Delineation for Conformal and Intensity Modulated Radiation Therapy;Lee,2015

4. A comparison of overall survival for patients with T4 larynx cancer treated with surgical versus organ-preservation approaches: A National Cancer Data Base analysis;Stokes;Cancer,2017

5. Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): A randomised, open-label, phase 3 study;Cohen;Lancet,2019

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case report: Patient specific combination of surgery and immunotherapy in advanced squamous cell carcinoma of the head and neck – a case series and review of literature;Frontiers in Immunology;2022-10-27

2. Retreatment of Recurrent or Second Primary Head and Neck Cancer After Prior Radiation: Executive Summary of the American Radium Society Appropriate Use Criteria;International Journal of Radiation Oncology*Biology*Physics;2022-07

3. Clinical and technical challenges of cancer reirradiation: Words of wisdom;Critical Reviews in Oncology/Hematology;2022-06

4. Adjuvant brachytherapy for oral squamous cell carcinomas: a single-center experience comparing low-dose and pulsed-dose-rate techniques;Strahlentherapie und Onkologie;2021-11-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3